Prelude Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$246K Buy
+1,095
New +$273K 0.02% 808
2025
Q2
Sell
-1,671
Closed -$374K 1300
2025
Q1
$374K Buy
1,671
+28
+2% +$6.54K 0.03% 611
2024
Q4
$376K Buy
+1,643
New +$396K 0.02% 701
2024
Q3
Sell
-3,145
Closed -$602K 1501
2024
Q2
$602K Sell
3,145
-5
-0.2% -$1.01K 0.04% 463
2024
Q1
$624K Buy
3,150
+1,385
+78% +$254K 0.03% 538
2023
Q4
$304K Sell
1,765
-620
-26% -$95.3K 0.02% 733
2023
Q3
$353K Sell
2,385
-143
-6% -$25.9K 0.02% 595
2023
Q2
$552K Buy
+2,528
New +$563K 0.04% 430
2022
Q1
Sell
-1,366
Closed -$356K 2164
2021
Q4
$356K Buy
1,366
+102
+8% +$26.5K 0.01% 1220
2021
Q3
$333K Buy
1,264
+283
+29% +$77.4K 0.01% 1087
2021
Q2
$242K Sell
981
-2,639
-73% -$555K 0.01% 1304
2021
Q1
$702K Buy
+3,620
New +$726K 0.02% 753
2020
Q4
Sell
-367
Closed -$63K 1875
2020
Q3
$63K Buy
+367
New +$67.8K ﹤0.01% 1060
2016
Q2
Sell
-1,122
Closed -$65K 1713
2016
Q1
$65K Buy
+1,122
New +$63.5K 0.01% 898
2014
Q1
Sell
-2,700
Closed -$127K 2072
2013
Q4
$127K Sell
2,700
-1,699
-39% -$86K 0.02% 778
2013
Q3
$232K Buy
+4,399
New +$213K 0.04% 497

Other funds holding RMD

Prelude Capital Management's RMD Position: Q1 2026 in Review

Prelude Capital Management opened a new position in ResMed (RMD) in Q1 2026: 1,095 shares worth $246K. The stake represents 0.02% of the portfolio and ranks #808 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in RMD as recently as Q1 2025.

Prelude Capital Management first reported a position in RMD in Q3 2013 and has held it in 16 quarters since. The position peaked at $702K in Q1 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Prelude Capital Management held 1,095 shares of ResMed worth $246K as of Q1 2026.
  • ResMed was a new Prelude Capital Management position in Q1 2026.
  • ResMed made up 0.02% of Prelude Capital Management's portfolio in Q1 2026, its #808 holding.
  • Prelude Capital Management first reported a position in ResMed in Q3 2013 and has held it in 16 quarters since.
  • Prelude Capital Management's ResMed position peaked at $702K in Q1 2021.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.